Route to improving Type 1 diabetes mellitus glycaemic outcomes: real‐world evidence taken from the National Diabetes Audit

Abstract

Aim To use general practice-level data for England, available through the National Diabetes Audit, and primary care prescribing data to identify prescription treatment factors associated with variations in achieved glucose control (HbA 1c ).Methods General practice-level National Diabetes Audit data on Type 1 diabetes, including details of population characteristics, services, proportion of people achieving target glycaemic control [HbA 1c ≤58 mmol/mol (7.5%)] and proportion of people at high glycaemic risk [HbA 1c >86 mmol/ml (10%)], were linked to 2013-2016 primary care diabetes prescribing data on insulin types and blood glucose monitoring for all people with diabetes.

Sodium‐glucose co‐transporter‐2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England

“…We accept that there is a lack of precise information in this study on time span between exposure and outcome. We have recently also described this in relation to (different) treatment variables in people with T1DM using a similar methodology …”

Patient perception of support within primary care is as important as medication and services in achieving good glycaemic control

“…The National Diabetes Audit (NDA) data provide us at GP practice level for type 1 diabetes (T1DM) and type 2 diabetes (T2DM) measures of clinical outcomes including the numbers hitting target HbA1c and also at elevated risk of complications. We have recently published multivariate analyses that linked the variation in these outcomes quantitatively to GP Practices in both their prescribing in type and amount of medication and their effectiveness in delivering their own diabetes service provision.…”

“…We have recently published 3,4 multivariate analyses that linked the variation in these outcomes quantitatively to GP Practices in both their prescribing in type and amount of medication and their effectiveness in delivering their own diabetes service provision.…”

Demographic factor clustering at a GP practice level in England and its relation to glycaemic outcomes: What we can learn from this

“…As described in our previous papers, a multiplicity of factors determine the outcome for people with both type 1 diabetes (T1DM) and type 2 diabetes (T2DM) when seen from the perspective of general practioner (GP) practice level data as reported by the National Diabetes Audit (NDA)…”